Shih-Ku Lin, MD
- 7Articles
- 29.4KReads
- 1999–2016Active
- 30Collaborators
- 334Citations
About
Shih-Ku Lin, MD, has authored multiple articles focusing on schizophrenia and schizoaffective disorders, addiction, suicide risk, and weight-related metabolic issues. The research topics include cardiovascular risks in methamphetamine users, effects of adjunctive metformin and fluvoxamine on metabolic disturbances in clozapine-treated patients, and the efficacy and safety of antipsychotic medications such as aripiprazole. Lin’s work also examines factors influencing suicide among patients with methamphetamine dependence and the impact of demographic variables on clozapine plasma levels. Collaborations frequently involve co-authors Chian-Jue Kuo, Hsien-Yuan Lane, and others.
Publications
Methamphetamine and Cardiovascular Disease and Stroke
October 26, 2016
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
